Local Alzheimer’s Association CEO discusses new drug approved for the disease
For nearly 20 years the Alzheimer's community has seen no medication progress until now.
MINNESOTA & NORTH DAKOTA (KVRR) — The FDA has given the go-ahead for a new Alzheimer’s drug. “We’re slowing down the progression of the disease or this drug will do that. That’s exciting because it will give people more time and a better quality of time while they’re with their families,” Alzheimer’s Association Minnesota-North Dakota CEO & Director Susan Parriott…
